Australia

Australia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.46 (0.33 - 0.62) 2015 Modelled WHO
1 (0.90 - 1) 2016 Modelled Razavi-Shearer et al, 2018
0.9 2018 Survey/reported Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2020
0.37 (0.36 - 0.38) 2013 Modelled Schweitzer et al, 2015
1.01 2015 Modelled Maclachlan et al, 2018
2.14 (1.94 - 2.34) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.46 (2.20 - 2.68) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (2.20 - 2.82) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.51 (2.25 - 2.79) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.52 (2.25 - 2.79) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.53 (2.27 - 2.79) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.33 - 2.82) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (2.38 - 2.86) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.65 (2.41 - 2.90) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (2.43 - 2.93) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.68 (2.45 - 2.93) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.72 (2.48 - 2.96) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.51 - 3) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.8 (2.55 - 3.04) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.82 (2.55 - 3.08) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.83 (2.57 - 3.07) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.60 - 3.10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.88 (2.62 - 3.13) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.91 (2.64 - 3.18) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.92 (2.65 - 3.21) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.94 (2.68 - 3.21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.71 - 3.25) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.01 (2.75 - 3.28) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.04 (2.76 - 3.33) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.06 (2.77 - 3.37) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.07 (2.79 - 3.36) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.07 (2.80 - 3.37) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.82 - 3.38) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.82 - 3.40) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.79 - 3.42) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.38 (2.15 - 2.60) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.15 (0.09 - 0.23) 2015 Modelled WHO
0.4 (0 - 2.20) 2002 Survey/reported WHO WPRO, Woodring J et al, 2017
0.07 (0.06 - 0.09) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.11 (0.09 - 0.14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.09 - 0.14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.09 - 0.14) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.15) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.16) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.17) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.17) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.17) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.11 - 0.17) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.17) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.11 - 0.17) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.11 - 0.17) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.11 - 0.17) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.11 - 0.17) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.11 - 0.17) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.11 - 0.17) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.11 - 0.18) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.12 - 0.19) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.13 - 0.20) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.14 - 0.23) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.24 - 0.40) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.47 - 0.77) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.75 - 1.21) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (0.97 - 1.60) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.4 (1.08 - 1.78) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.41 (1.10 - 1.79) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.41 (1.10 - 1.78) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.39 (1.10 - 1.77) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.37 (1.07 - 1.76) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (1.04 - 1.74) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.11 - 0.16) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.7 2018 Survey/reported Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2024
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
2.8 2018 Survey/reported Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2022
Aboriginal and/or Torres Strait Islander people
Download
Value (%) Year Type Source
2 2018 Survey/reported Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2023
People born overseas
Download
Value (%) Year Type Source
1.9 2018 Survey/reported Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2025
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
234,000 (222,000 - 252,000) 2016 Modelled Razavi-Shearer et al, 2018
226,566 2018 Survey/reported Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2021
233,947 (222,706 - 246,015) 2017 Survey/reported The Kirby Institute, 2018
230,034 (219,465 - 249,457) 2016 Survey/reported The Kirby Institute, 2017
525,919 (477,108 - 573,902) 2019 Modelled IHME, GBD 2019 (accessed 2020)
546,429 (494,974 - 596,405) 2019 Modelled IHME, GBD 2019 (accessed 2022)
561,837 (503,865 - 612,992) 2018 Modelled IHME, GBD 2019 (accessed 2022)
564,609 (496,769 - 638,444) 2017 Modelled IHME, GBD 2019 (accessed 2022)
557,618 (499,962 - 621,592) 2016 Modelled IHME, GBD 2019 (accessed 2022)
550,652 (490,683 - 611,628) 2015 Modelled IHME, GBD 2019 (accessed 2022)
545,446 (490,243 - 602,298) 2014 Modelled IHME, GBD 2019 (accessed 2022)
544,061 (493,527 - 596,074) 2013 Modelled IHME, GBD 2019 (accessed 2022)
543,947 (495,574 - 595,610) 2012 Modelled IHME, GBD 2019 (accessed 2022)
542,567 (493,449 - 595,647) 2011 Modelled IHME, GBD 2019 (accessed 2022)
537,454 (489,645 - 591,697) 2010 Modelled IHME, GBD 2019 (accessed 2022)
532,589 (485,911 - 582,138) 2009 Modelled IHME, GBD 2019 (accessed 2022)
531,917 (484,708 - 578,038) 2008 Modelled IHME, GBD 2019 (accessed 2022)
532,761 (484,908 - 578,243) 2007 Modelled IHME, GBD 2019 (accessed 2022)
532,355 (483,447 - 577,654) 2006 Modelled IHME, GBD 2019 (accessed 2022)
528,200 (477,298 - 576,203) 2005 Modelled IHME, GBD 2019 (accessed 2022)
523,653 (475,185 - 569,401) 2004 Modelled IHME, GBD 2019 (accessed 2022)
522,333 (475,289 - 566,685) 2003 Modelled IHME, GBD 2019 (accessed 2022)
522,313 (476,064 - 567,325) 2002 Modelled IHME, GBD 2019 (accessed 2022)
521,643 (474,899 - 569,565) 2001 Modelled IHME, GBD 2019 (accessed 2022)
518,395 (470,252 - 567,996) 2000 Modelled IHME, GBD 2019 (accessed 2022)
514,723 (469,008 - 561,889) 1999 Modelled IHME, GBD 2019 (accessed 2022)
513,053 (468,281 - 560,023) 1998 Modelled IHME, GBD 2019 (accessed 2022)
512,184 (467,103 - 557,984) 1997 Modelled IHME, GBD 2019 (accessed 2022)
510,810 (462,406 - 559,299) 1996 Modelled IHME, GBD 2019 (accessed 2022)
507,664 (457,113 - 555,855) 1995 Modelled IHME, GBD 2019 (accessed 2022)
503,478 (456,882 - 551,601) 1994 Modelled IHME, GBD 2019 (accessed 2022)
499,388 (456,008 - 547,929) 1993 Modelled IHME, GBD 2019 (accessed 2022)
495,130 (454,063 - 543,191) 1992 Modelled IHME, GBD 2019 (accessed 2022)
490,520 (448,342 - 540,557) 1991 Modelled IHME, GBD 2019 (accessed 2022)
485,428 (439,651 - 538,037) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.19 (1.74 - 2.74) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.98 (1.55 - 2.47) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.57 - 2.49) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.62 - 2.55) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.64 - 2.57) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.14 (1.69 - 2.65) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.71 - 2.65) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.74 - 2.69) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.21 (1.76 - 2.71) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.77 - 2.69) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.76 - 2.70) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.22 (1.78 - 2.72) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.35 (1.89 - 2.87) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.26 (1.81 - 2.77) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.42 (1.94 - 2.95) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (1.98 - 2.98) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (1.99 - 2.97) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (2.01 - 3.01) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.36 (1.90 - 2.87) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.21 (1.77 - 2.73) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.02 (1.60 - 2.52) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.06 (1.64 - 2.56) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.64 - 2.58) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.09 (1.66 - 2.62) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.23 (1.77 - 2.80) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.72 - 2.71) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.27 (1.80 - 2.85) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.22 (1.76 - 2.78) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.18 (1.74 - 2.74) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.18 (1.74 - 2.73) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.74 - 2.74) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,634 2016 Modelled WHO
333 (262 - 417) 1990 Modelled IHME, GBD 2019 (accessed 2022)
342 (269 - 426) 1991 Modelled IHME, GBD 2019 (accessed 2022)
355 (280 - 441) 1992 Modelled IHME, GBD 2019 (accessed 2022)
364 (288 - 450) 1993 Modelled IHME, GBD 2019 (accessed 2022)
379 (299 - 468) 1994 Modelled IHME, GBD 2019 (accessed 2022)
385 (306 - 474) 1995 Modelled IHME, GBD 2019 (accessed 2022)
396 (315 - 487) 1996 Modelled IHME, GBD 2019 (accessed 2022)
403 (321 - 495) 1997 Modelled IHME, GBD 2019 (accessed 2022)
405 (326 - 496) 1998 Modelled IHME, GBD 2019 (accessed 2022)
410 (329 - 503) 1999 Modelled IHME, GBD 2019 (accessed 2022)
418 (336 - 513) 2000 Modelled IHME, GBD 2019 (accessed 2022)
455 (365 - 554) 2002 Modelled IHME, GBD 2019 (accessed 2022)
432 (346 - 529) 2001 Modelled IHME, GBD 2019 (accessed 2022)
487 (392 - 591) 2004 Modelled IHME, GBD 2019 (accessed 2022)
475 (380 - 578) 2003 Modelled IHME, GBD 2019 (accessed 2022)
501 (403 - 605) 2005 Modelled IHME, GBD 2019 (accessed 2022)
488 (392 - 594) 2007 Modelled IHME, GBD 2019 (accessed 2022)
501 (405 - 605) 2006 Modelled IHME, GBD 2019 (accessed 2022)
439 (348 - 544) 2009 Modelled IHME, GBD 2019 (accessed 2022)
464 (370 - 572) 2008 Modelled IHME, GBD 2019 (accessed 2022)
454 (360 - 566) 2011 Modelled IHME, GBD 2019 (accessed 2022)
436 (345 - 544) 2010 Modelled IHME, GBD 2019 (accessed 2022)
466 (369 - 583) 2012 Modelled IHME, GBD 2019 (accessed 2022)
489 (388 - 613) 2013 Modelled IHME, GBD 2019 (accessed 2022)
523 (417 - 656) 2016 Modelled IHME, GBD 2019 (accessed 2022)
527 (419 - 662) 2015 Modelled IHME, GBD 2019 (accessed 2022)
512 (407 - 641) 2014 Modelled IHME, GBD 2019 (accessed 2022)
522 (416 - 655) 2017 Modelled IHME, GBD 2019 (accessed 2022)
530 (422 - 663) 2018 Modelled IHME, GBD 2019 (accessed 2022)
537 (427 - 674) 2019 Modelled IHME, GBD 2019 (accessed 2022)
537 (427 - 674) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
5 (3 - 7) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2001 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2005 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2008 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2010 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 18) 2012 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 19) 2013 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 19) 2016 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 19) 2015 Modelled IHME, GBD 2019 (accessed 2022)
14 (9 - 19) 2014 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 18) 2017 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 18) 2018 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 18) 2019 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
94.7 2018 Survey/reported Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2027
95 2019 Survey/reported WHO/UNICEF
95 2020 Survey/reported WHO/UNICEF
95 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
461 (364 - 631) 2016 Survey/reported Iversen J et al, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
41.8 (39.80 - 43.90) 2015 Survey/reported Memedovic S et al, 2016
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2000
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.78 2016 Survey/reported Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2028
0.74 (0.52 - 0.78) 2017 Survey/reported The Kirby Institute, 2018
1 (0.70 - 1) 2015 Modelled Blach et al, 2017
1.62 (1.27 - 2.04) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.27 - 2) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.26 - 2.01) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.62 (1.29 - 2.01) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.31 - 2.05) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.33 - 2.07) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.34 - 2.08) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.35 - 2.09) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.36 - 2.11) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.36 - 2.11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.36 - 2.11) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.35 - 2.10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.33 - 2.08) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.30 - 2.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.62 (1.28 - 2.07) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.29 - 2.05) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.32 - 2.05) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.34 - 2.05) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.36 - 2.06) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.38 - 2.07) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.71 (1.40 - 2.09) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.44 - 2.12) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.47 - 2.15) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.49 - 2.18) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.82 (1.49 - 2.20) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.49 - 2.18) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (1.48 - 2.17) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.46 - 2.16) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.43 - 2.13) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.71 (1.39 - 2.12) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.5 (1.18 - 1.90) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
51 2016 Survey/reported The Kirby Institute, 2017
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.54 (0.41 - 0.57) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.3 2019 Modelled Jin et al. 2017
1.7 (1.20 - 1.80) 2014 Modelled Gower et al, 2014
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
8.7 (7.60 - 9.90) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
53.5 (50.20 - 56.90) 2014 Modelled Degenhardt L et al, 2017
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
2.8 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
230,000 (178,000 - 244,000) 2015 Modelled Blach et al, 2017
199,412 (145,585 - 210,403) 2016 Survey/reported The Kirby Institute, 2017
182,144 (128,845 - 192,981) 2017 Survey/reported The Kirby Institute, 2018
269,362 (218,617 - 331,892) 1990 Modelled IHME, GBD 2019 (accessed 2022)
278,293 (227,926 - 339,152) 1991 Modelled IHME, GBD 2019 (accessed 2022)
285,875 (235,413 - 346,852) 1992 Modelled IHME, GBD 2019 (accessed 2022)
292,220 (241,475 - 351,849) 1993 Modelled IHME, GBD 2019 (accessed 2022)
297,523 (244,452 - 358,063) 1994 Modelled IHME, GBD 2019 (accessed 2022)
302,022 (246,961 - 363,691) 1995 Modelled IHME, GBD 2019 (accessed 2022)
304,421 (251,389 - 366,991) 1996 Modelled IHME, GBD 2019 (accessed 2022)
303,865 (250,657 - 366,896) 1997 Modelled IHME, GBD 2019 (accessed 2022)
301,719 (249,086 - 366,041) 1998 Modelled IHME, GBD 2019 (accessed 2022)
299,513 (245,816 - 366,392) 1999 Modelled IHME, GBD 2019 (accessed 2022)
298,793 (243,663 - 367,777) 2000 Modelled IHME, GBD 2019 (accessed 2022)
299,050 (244,372 - 369,638) 2001 Modelled IHME, GBD 2019 (accessed 2022)
298,924 (242,764 - 371,278) 2002 Modelled IHME, GBD 2019 (accessed 2022)
299,164 (240,964 - 377,103) 2003 Modelled IHME, GBD 2019 (accessed 2022)
300,592 (238,960 - 379,013) 2004 Modelled IHME, GBD 2019 (accessed 2022)
303,998 (240,341 - 386,810) 2005 Modelled IHME, GBD 2019 (accessed 2022)
310,097 (246,813 - 392,570) 2006 Modelled IHME, GBD 2019 (accessed 2022)
318,026 (256,521 - 402,131) 2007 Modelled IHME, GBD 2019 (accessed 2022)
326,638 (263,934 - 413,361) 2008 Modelled IHME, GBD 2019 (accessed 2022)
334,888 (269,383 - 419,136) 2009 Modelled IHME, GBD 2019 (accessed 2022)
341,434 (273,120 - 426,014) 2010 Modelled IHME, GBD 2019 (accessed 2022)
346,084 (277,332 - 431,972) 2011 Modelled IHME, GBD 2019 (accessed 2022)
349,895 (281,331 - 436,096) 2012 Modelled IHME, GBD 2019 (accessed 2022)
353,067 (282,818 - 440,695) 2013 Modelled IHME, GBD 2019 (accessed 2022)
356,123 (285,531 - 446,046) 2014 Modelled IHME, GBD 2019 (accessed 2022)
359,707 (286,907 - 449,105) 2015 Modelled IHME, GBD 2019 (accessed 2022)
359,807 (286,998 - 447,064) 2016 Modelled IHME, GBD 2019 (accessed 2022)
360,402 (285,344 - 453,482) 2017 Modelled IHME, GBD 2019 (accessed 2022)
365,598 (289,446 - 457,318) 2018 Modelled IHME, GBD 2019 (accessed 2022)
368,380 (288,926 - 466,027) 2019 Modelled IHME, GBD 2019 (accessed 2020)
371,124 (291,406 - 468,733) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
31,500 (24,300 - 33,400) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
6.37 (5.29 - 7.31) 2019 Modelled IHME, GBD 2019 (accessed 2020)
4.12 (3.49 - 4.71) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4.08 (3.46 - 4.66) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.1 (3.49 - 4.67) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.1 (3.47 - 4.68) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.18 (3.53 - 4.76) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.18 (3.54 - 4.77) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.24 (3.58 - 4.84) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.26 (3.60 - 4.84) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.23 (3.58 - 4.80) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.25 (3.59 - 4.84) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.28 (3.61 - 4.90) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.51 (3.79 - 5.16) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.36 (3.67 - 4.99) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.61 (3.87 - 5.26) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.65 (3.92 - 5.32) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.71 (3.97 - 5.40) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.82 (4.04 - 5.51) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.28 (4.40 - 6.03) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.04 (4.23 - 5.77) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.43 (4.55 - 6.22) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.59 (4.69 - 6.42) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.84 (4.93 - 6.69) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.75 (4.85 - 6.60) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6.05 (5.12 - 6.92) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6.4 (5.41 - 7.36) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6.26 (5.27 - 7.18) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6.38 (5.33 - 7.29) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6.34 (5.31 - 7.27) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6.4 (5.34 - 7.35) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6.37 (5.29 - 7.31) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
335 2016 Modelled WHO
621 2016 Survey/reported Australia Fifth National Hepatitis C Strategy 2018-2022
1,564 (1,301 - 1,797) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,564 (1,301 - 1,797) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,552 (1,295 - 1,784) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,519 (1,271 - 1,740) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,506 (1,258 - 1,722) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,491 (1,259 - 1,713) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,437 (1,209 - 1,648) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,368 (1,157 - 1,565) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,301 (1,097 - 1,490) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,260 (1,063 - 1,446) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,206 (1,013 - 1,386) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,156 (968 - 1,323) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,106 (923 - 1,264) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,041 (874 - 1,192) 2007 Modelled IHME, GBD 2019 (accessed 2022)
981 (824 - 1,122) 2006 Modelled IHME, GBD 2019 (accessed 2022)
946 (798 - 1,084) 2005 Modelled IHME, GBD 2019 (accessed 2022)
921 (777 - 1,055) 2004 Modelled IHME, GBD 2019 (accessed 2022)
902 (758 - 1,029) 2003 Modelled IHME, GBD 2019 (accessed 2022)
872 (732 - 998) 2002 Modelled IHME, GBD 2019 (accessed 2022)
833 (701 - 953) 2001 Modelled IHME, GBD 2019 (accessed 2022)
809 (681 - 925) 2000 Modelled IHME, GBD 2019 (accessed 2022)
793 (670 - 904) 1999 Modelled IHME, GBD 2019 (accessed 2022)
780 (660 - 886) 1998 Modelled IHME, GBD 2019 (accessed 2022)
778 (657 - 885) 1997 Modelled IHME, GBD 2019 (accessed 2022)
767 (646 - 874) 1996 Modelled IHME, GBD 2019 (accessed 2022)
748 (632 - 854) 1995 Modelled IHME, GBD 2019 (accessed 2022)
740 (625 - 843) 1994 Modelled IHME, GBD 2019 (accessed 2022)
718 (608 - 820) 1993 Modelled IHME, GBD 2019 (accessed 2022)
709 (604 - 808) 1992 Modelled IHME, GBD 2019 (accessed 2022)
698 (591 - 796) 1991 Modelled IHME, GBD 2019 (accessed 2022)
695 (589 - 794) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
10 (7 - 13) 1990 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 14) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1992 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 1995 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 16) 1994 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 1996 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 1997 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 20) 1998 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 22) 2000 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 2001 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 27) 2004 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 2002 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2003 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 29) 2005 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 31) 2006 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 32) 2007 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 35) 2009 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 34) 2008 Modelled IHME, GBD 2019 (accessed 2022)
29 (21 - 37) 2010 Modelled IHME, GBD 2019 (accessed 2022)
33 (24 - 42) 2012 Modelled IHME, GBD 2019 (accessed 2022)
31 (23 - 40) 2011 Modelled IHME, GBD 2019 (accessed 2022)
35 (26 - 45) 2013 Modelled IHME, GBD 2019 (accessed 2022)
36 (26 - 46) 2014 Modelled IHME, GBD 2019 (accessed 2022)
36 (26 - 47) 2015 Modelled IHME, GBD 2019 (accessed 2022)
37 (27 - 47) 2016 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 47) 2017 Modelled IHME, GBD 2019 (accessed 2022)
36 (26 - 46) 2018 Modelled IHME, GBD 2019 (accessed 2022)
34 (25 - 45) 2019 Modelled IHME, GBD 2019 (accessed 2022)
34 (25 - 43) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
30,434 2016 Survey/reported The Kirby Institute, 2017
4,340 2015 Survey/reported The Kirby Institute, 2019
Showing out of
Show more
Females
Download
Value Year Type Source
23,186 2018 Survey/reported The Kirby Institute, 2019
Males
Download
Value Year Type Source
47,074 2018 Survey/reported The Kirby Institute, 2019
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
461 (364 - 631) 2016 Survey/reported Iversen J et al, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
41.8 (39.80 - 43.90) 2015 Survey/reported Memedovic S et al, 2016
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2000
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
2.38 (%)
2019
(2.15 - 2.6(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
1.5 (%)
2019
(1.18 - 1.9(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

HBV (HBsAg+)
0.9 (%)
2018
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, 2020
No data available

Hepatitis related deaths (national)

Modelled

HBV
537
2019
(427 - 674)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,564
2019
(1,301 - 1,797)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HCV
621
2016
Australia Fifth National Hepatitis C Strategy 2018-2022
HCV chart

Prevalence < 5

HBV
0.13 (%)
2020, latest modelled
(0.11 - 0.16(%))
WHO

Prevalence PWID

HCV
53.50 (%)
2014, latest modelled
(50.20 - 56.90(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
461
2016
(364 - 631)
Iversen J et al, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

Action plan

View all

News

Action plans

Resources

Partners